Coagulation and fibrinolysis factors in healthy subjects consuming high stearic or trans fatty acid diets

Thrombosis and Haemostasis

Volumn 77, Issue 1, 1997, Pages 99-104

  Mutanen, Marja ^a   Aro, Antti ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CHOLESTEROL; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HYDROGENATED VEGETABLE OIL; LIPOPROTEIN A; MONOUNSATURATED FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CALORIC INTAKE; CONTROLLED STUDY; DAIRY PRODUCT; FAT INTAKE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031055635     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655914     Document Type: Article

References (46)

1. Katan MB, Zock PL, Mensink RP. Trans fatty acids and their effects on lipoproteins in humans. Ann Rev Nutr 1995; 15: 473-93.
2. Nestel P, Noakes M, Belling B, McArthur R, Clifton P, Janus E, Abbey M. Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 1992; 33: 1029-36.
3. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. J Lipid Res 1992, 33: 1493-501.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50, 310-8.
5. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993, 100: 1-12.
6. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
7. Hamsten A, Wirman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-63.
8. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
9. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-3.
10. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-Dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994; 90: 2236-40.
11. Marckmann P, Sandström B, Jespersen J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischaemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-9.
12. Brace LD, Gittler-Buffa C, Miller GJ, Cole TG, Schmeisser D, Prewitt TE, Bowen PE. Factor VII coagulant activity and cholesterol changes in pre-menopausal women consuming a long-term cholesterol-lowering diet. ArteriosclerThromb 1994; 14: 1284-9.
13. Marckmann P, Sandström B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505-11.
14. Mehta J, Lawson D, Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J 1988; 116: 1201-6.
15. Tholstrup T, Marckmann P, Jespersen J, Sandström B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr 1994; 59: 371-7.
16. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. IV. Particular saturated fatty acids in the diet. Metabolism 1965; 14: 776-87.
17. Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med 1988; 318: 1244-8.
18. Yu S, Derr J, Etherton TD, Kris-Etherton PM. Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. Am J Clin Nutr 1995; 61: 1129-39.
19. Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J. Dietary changes in fasting levels of factor VII coagulant activity (VII: C) are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995; 73: 239-42.
20. Miller GJ, Cruickshank JK, Ellis LJ, Thompson RL, Wilkes HC, Stirling Y, Mitropoulos KA, Allison JV, Fox TE, Walöker AO. Fat consumption and factor VII coagulant activity in middle-aged men. Atherosclerosis 1989; 78: 19-24.
21. Zock PL, Blijlevens RAMT, de Vries JHM, Katan MB. Effect of stearic acid and trans fatty acids versus linoleic acid on blood pressure in normotensive women and men. Eur J Clin Nutr 1993; 47: 437-44.
22. Nilsson K, Rosen S, Friberger P. A new kit for the determination of tissue plasminogen activator and its inhibitor in blood. Fibrinolysis 1987; 1: 163-8.
23. Sundvall J, Sulonen G-B, Hiltunen O, Kiuru J, Pursiainen M, Jauhiainen M. Comparison of a new immunoturbidometric assay of human serum lipoprotein(a) to the ELISA and IRMA methods. Scand J Lab Invest 1995; 55: 171-80.
24. Dudley PA, Anderson RE. Separation of polyunsaturated fatty acids by argentation thin layer chromatography. Lipids 1975, 10: 113-5.
25. Rossi E, Mondonico P, Lombardi A, Preda L. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52: 453-68.
26. Denson KW. The specific assay of Prower-Stuart and factor VII. Acta Haematol 1961; 25: 105-20.
27. SYSTAT. Statistics, Version 5.2 Edition. Evanston, IL, Systat, Inc. 1992; pp 724.
28. Almendingen K, Seljeflot I, Sandstad B, Pedersen JI. Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men. Arterioscler Thromb Vase Biol 1996, 16: 375-80.
29. Renaud S, Dumont E, Godsey F, Morazain R, Thevenon C, Ortchanian E. Dietary fats and platelet function in French and Scottish farmers. Nutr Metab 1980; 24 (Suppl): 90-104.
30. Hornstra G. Dietary fats, prostanoids and arterial thrombosis. Developments in hematology and immunology 1982; 4.
31. Rankinen T, Väisänen T, Penttilä I, Rauramaa R. Acute dynamic exercise increases fibrinolytic activity. Thromb Haemost 1995; 73: 281-6.
32. Stevenson ET, Davy KP, Seals DR. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women. Arterioscler Thromb Vasc Biol 1995, 15: 669-77.
33. Haines AP, Chakrabarti R, Fisher D, Meade TW, North WRS, Stirling Y. Haemostatic variables in vegetarians and non-vegetarians. Thromb Res 1980; 19: 139-48.
34. Marckmann P, Jespersen J, Leth T, Sandström B. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Int Med 1991; 229: 317-23.
35. Slabber M, Barnard HC, Kuyl JM, Badenhorst CJ. Effect of a short-term very low caloric diet on plasma lipids, fibrinogen, and factor VII in obese subjects. Clin Biochem 1992, 25: 334-5.
36. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-33.
37. Marckmann P, Sandström B, Jespersen J. Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 1992, 12: 201-5.
38. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly. Am J Epidemiol 1996; 143: 665-76.
39. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214-22.
40. Jerling JC, Vorster HH, Oosthuizen W, Silvis N, Venter CS. Differences in plasminogen activator inhibitor 1 activity between blacks and whites may be diet related. Haemostasis 1994, 24: 364-8.
41. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-71.
42. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240-5.
43. Etingin O, Hajjar D, Hajjar K, Harpel P, Nachman R. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 1991; 266: 2459-65.
44. Graeff H, Hafter R. Detection and relevance of cross linked fibrin derivatives in blood. Sem Thromb Haemost 1982, 8: 57-68.
45. Lassila R, Peltonen S, Lepäntalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb 1993; 13: 1738-42.
46. Ceriello A, Pirisi M, Giacomello R, Stel G, Falleti E, Motz E, Lizzio S, Gonano F, Bartoli E. Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost 1994; 71: 593-5.